Minims Tropicamide (Tropicamide)

Tropicamide blocks muscarinic (M3) receptors in the iris sphincter and ciliary body. This antagonism prevents acetylcholine‑mediated contraction, leading to relaxation of the sphincter muscle (mydriasis) and the ciliary muscle (cycloplegia), which together produce a widened pupil.

The specific dose and frequency are determined by the prescribing eye care professional based on the patient’s age, condition, and the procedure being performed. Only a qualified prescriber should set the appropriate regimen.

Safety data for tropicamide in pregnancy and lactation are limited. It should be used only if the potential benefit justifies any potential risk to the fetus or infant, and the decision should be made by the treating physician.

To request Minims Tropicamide, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Tropicamide has a rapid onset and relatively short duration of action compared with agents such as phenylephrine or cyclopentolate. This makes it suitable for routine diagnostic dilation, whereas longer‑acting agents may be preferred for procedures requiring extended cycloplegia.

Store at ambient temperature: keep the bottle in its original packaging, protect it from direct light and moisture, and do not freeze. Ensure the container is tightly closed when not in use.

Minims Tropicamide is applied topically to the eye as a sterile solution. The prescriber typically instills one or more drops into the conjunctival sac, following aseptic technique and allowing sufficient time for the drug to take effect before the examination or procedure.

The most serious risks include acute angle‑closure glaucoma, which can cause a rapid increase in intra‑ocular pressure, and severe allergic reactions such as anaphylaxis. Patients should be monitored for signs of pain, vision changes, or systemic symptoms and seek immediate medical attention if they occur.

Patients with known hypersensitivity to tropicamide or other anticholinergic eye drops, those with narrow‑angle or uncontrolled glaucoma, and individuals for whom pupil dilation could compromise visual function should avoid using Minims Tropicamide unless specifically directed by a qualified eye care professional.